What factors will most influence your decision to offer ENCELTO to patients with macular telangiectasia type 2?
Answer from: at Community Practice
Yet another (presumably very expensive) surgical treatment for a chronic macular disease was approved on the basis of OCT measurements without demonstrating visual benefit to the patient in a disease with a slow, variable course.
Show me quality of life studies and visual benefit justifying surgica...
Comments
at The Retina Center The cost is going to be a major factor. This seem...
The cost is going to be a major factor. This seem...